Evaluation of NAD(H) analogues as selective inhibitors for Trypanosoma cruzi S-adenosylhomocysteine hydrolase

Nucleosides Nucleotides Nucleic Acids. 2009 May;28(5):473-84. doi: 10.1080/15257770903044572.

Abstract

S-Adenosylhomocysteine (AdoHcy) hydrolases (SAHHs) from human sources (Hs-SAHHs) bind the cofactor NAD(+) more tightly than several parasitic SAHHs by around 1000-fold. This property suggests the cofactor binding site of this essential enzyme as a potential anti-parasitic drug target, e.g., against SAHH from Trypansoma cruzi (Tc-SAHH). The on-rate and off-rate constants and the equilibrium dissociation constants were determined for NAD(+)/NADH analogues and suggested that NADH analogues were the most promising for selective inhibition of Tc-SAHH. None significantly inhibited Hs-SAHH while S-NADH and H-NADH (see Figure 1) reduced the catalytic activity of Tc-SAHH to < 10% in six minutes of exposure.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosylhomocysteinase / antagonists & inhibitors*
  • Adenosylhomocysteinase / metabolism*
  • Chagas Disease / drug therapy
  • Humans
  • NAD / analogs & derivatives*
  • Trypanocidal Agents / chemistry*
  • Trypanocidal Agents / pharmacology*
  • Trypanosoma cruzi / drug effects
  • Trypanosoma cruzi / enzymology*

Substances

  • Trypanocidal Agents
  • NAD
  • Adenosylhomocysteinase